{"id":"https://openalex.org/W2603233559","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","title":"A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors.","display_name":"A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2603233559","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","mag":"2603233559"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.tps2107","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049546835","display_name":"Yousef Zakharia","orcid":"https://orcid.org/0000-0001-9480-2626","observed_orcids":["https://orcid.org/0000-0001-9480-2626"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yousef Zakharia","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033744020","display_name":"Theodore S. Johnson","orcid":"https://orcid.org/0000-0002-4290-891X","observed_orcids":["https://orcid.org/0000-0002-4290-891X"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodore S. Johnson","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047608444","display_name":"Howard Colman","orcid":"https://orcid.org/0000-0002-4027-7317","observed_orcids":["https://orcid.org/0000-0002-4027-7317"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Colman","raw_affiliation_strings":["University of Utah Huntsman Cancer Institute, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Utah Huntsman Cancer Institute, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070688456","display_name":"Nicholas N. Vahanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas N. Vahanian","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112243123","display_name":"Charles J. Link","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles J. Link","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075592761","display_name":"Eugene Paul Kennedy","orcid":"https://orcid.org/0009-0008-7418-3774","observed_orcids":["https://orcid.org/0009-0008-7418-3774"]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugene Kennedy","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ramses F. Sadek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramses F. Sadek","raw_affiliation_strings":["Department of Biostatistics and Epidemiology, Georgia Regents University, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Epidemiology, Georgia Regents University, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087107933","display_name":"Feng\u2010Ming Kong","orcid":"https://orcid.org/0000-0003-2652-098X","observed_orcids":["https://orcid.org/0000-0003-2652-098X"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng Ming Kong","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110391971","display_name":"John R. Vender","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Vender","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011462362","display_name":"David H. Munn","orcid":"https://orcid.org/0000-0002-7711-2858","observed_orcids":["https://orcid.org/0000-0002-7711-2858"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Munn","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055791669","display_name":"Olivier Rixe","orcid":"https://orcid.org/0009-0005-7660-1739","observed_orcids":["https://orcid.org/0009-0005-7660-1739"]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivier Rixe","raw_affiliation_strings":["Georgia Regents University Cancer Center, Augusta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgia Regents University Cancer Center, Augusta, GA","institution_ids":["https://openalex.org/I25041050"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"TPS2107","last_page":"TPS2107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indoximod","display_name":"indoximod","score":0.9929999709129333},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":1.0},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/ido-inhibition","display_name":"IDO inhibition","score":0.7319999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5189999938011169},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7369999885559082},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8899999856948853},{"id":"https://openalex.org/keywords/stereotactic-radiosurgery","display_name":"stereotactic radiosurgery","score":0.9990000128746033},{"id":"https://openalex.org/keywords/kynurenine","display_name":"kynurenine","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tryptophan","display_name":"tryptophan","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cd4-cd8-ratio","display_name":"CD4/CD8 ratio","score":0.7329999804496765},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.7110000252723694},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6949999928474426},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.515999972820282},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.952796459197998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.905829668045044},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7156815528869629},{"id":"https://openalex.org/C2780387249","wikidata":"https://www.wikidata.org/wiki/Q973234","display_name":"Radiosurgery","level":3,"score":0.6179788112640381},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5826514959335327},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5718235969543457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5362815856933594},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45443102717399597},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4366539418697357},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.41887056827545166},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.356886088848114},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.35217809677124023},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2903190553188324},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2754766047000885},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.tps2107","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps2107","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030339795","https://openalex.org/W2602385701","https://openalex.org/W2277062205","https://openalex.org/W2587838108","https://openalex.org/W3216151000","https://openalex.org/W2836361791","https://openalex.org/W2767993501","https://openalex.org/W2184759047","https://openalex.org/W4400961916","https://openalex.org/W4386800579"],"abstract_inverted_index":{"TPS2107":[0],"Background:":[1],"Indoleamine":[2],"2,":[3],"3-dioxygenase":[4],"(IDO)":[5],"is":[6,25,44,101,251],"a":[7,28,74,87,163,181,232],"key":[8],"immune-modulatory":[9],"endogenous":[10],"enzyme":[11],"that":[12],"inhibits":[13],"CD8+":[14],"T":[15,62,279],"cells":[16,280],"and":[17,84,210,224,291,293],"enhances":[18],"the":[19,127,130,138,189,239,242,254],"suppressor":[20],"activity":[21,128,289],"of":[22,31,38,77,95,108,129,140,169,185,257,287],"Tregs.":[23],"IDO":[24,42,51,276,288],"expressed":[26],"in":[27,49,69,86,110,114,133,145,162,188,248],"large":[29],"proportion":[30],"solid":[32],"tumors,":[33],"including":[34,137],"50%":[35],"to":[36,102,151],"90%":[37],"glioblastomas":[39],"(GBMs).":[40],"High":[41],"expression":[43],"correlated":[45],"with":[46,81,112,156,180,203,208,222],"poor":[47],"prognosis":[48],"GBM.":[50,115],"inhibitors":[52],"such":[53],"as":[54],"indoximod":[55,78,109,170,202,207,221,294],"(1-Methyl-D-tryptophan":[56],"/":[57],"D-1MT)":[58],"can":[59],"improve":[60],"anti-tumor":[61],"cell":[63],"responses":[64],"which":[65],"slows":[66],"tumor":[67,91,271],"growth":[68],"vivo.":[70],"We":[71],"have":[72],"demonstrated":[73],"synergistic":[75],"effect":[76],"when":[79],"combined":[80],"temozolomide":[82],"(TMZ)":[83],"radiation":[85],"syngeneic":[88],"orthotopic":[89],"brain":[90],"model.":[92],"The":[93,229],"purpose":[94],"this":[96],"ongoing":[97],"phase":[98,123,164,190,249],"I":[99,165],"study":[100,168,230,267],"determine":[103],"maximal":[104,243],"tolerated":[105],"dose":[106,166,184,234],"(MTD)":[107],"combination":[111,132],"TMZ":[113,209,223],"This":[116,266],"will":[117,194,268],"be":[118,195],"followed":[119],"by":[120],"an":[121],"expansion":[122],"II":[124,191,250],"cohort,":[125],"testing":[126],"indoximod-TMZ":[131],"several":[134],"relevant":[135],"situations,":[136],"addition":[139],"bevacizumab":[141,211],"or":[142,173,241],"stereotactic":[143,225],"radiosurgery":[144],"clinically-indicated":[146],"cases.":[147],"Methods:":[148],"After":[149],"progression":[150,260],"standard":[152,182],"front":[153],"line-therapy,":[154],"patients":[155,193,213],"GBM":[157],"are":[158,215],"currently":[159,216],"being":[160],"enrolled":[161],"escalation":[167,235],"(600,":[171],"1000":[172],"1200":[174],"mg":[175],"twice":[176],"daily":[177],"given":[178],"orally)":[179],"fixed":[183],"TMZ.":[186],"Then,":[187],"portion,":[192],"separated":[196],"into":[197],"3":[198],"cohorts:":[199],"Cohort":[200],"2a:":[201],"TMZ,":[204],"cohort":[205,219],"2b:":[206],"(for":[212],"who":[214],"on":[217,253],"bevacizumab),":[218],"2c:":[220],"radiosurgery.":[226],"Statistical":[227],"analysis:":[228],"uses":[231],"3+3":[233],"design,":[236],"until":[237],"reaching":[238],"MTD":[240],"absorbed":[244],"dose.":[245],"Sample":[246],"size":[247],"based":[252],"primary":[255,270],"endpoint":[256],"6":[258],"months":[259],"free":[261],"survival":[262],"(PFS).":[263],"Correlative":[264],"studies:":[265],"assess":[269],"samples":[272],"for":[273,285],"methylguanine-DNA":[274],"methyltransferase,":[275],"expression,":[277],"intra-tumoral":[278],"(CD4:CD8":[281],"ratio);":[282],"patient":[283],"serum":[284],"biomarkers":[286],"(kynurenine":[290],"tryptophan)":[292],"pharmacokinetics.":[295],"Clinical":[296],"trial":[297],"information:":[298],"NCT02052648.":[299]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}